adminBiodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET
Company Participants
Robin Harper Cowie – CFO, Secretary & Treasurer
Scott Hutton – President, CEO & Director
Conference Call Participants
Alexander Davis Vukasin – Canaccord Genuity Corp., Research Division
Andrew Frederick Brackmann – William Blair & Company L.L.C., Research Division
Thomas Flaten – Lake Street Capital Markets, LLC, Research Division
William Ruby – TD Cowen, Research Division
William Bishop Bonello – Craig-Hallum Capital Group LLC, Research Division
Christopher F. Brinzey – Westwicke Partners, LLC
Operator
Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, Chris Brinzey. Please go ahead.
Christopher F. Brinzey
Thank you, operator, and good afternoon, everyone. Today, Biodesix released results from the second quarter of 2025. Leading the call today will be Scott Hutton, Chief Executive Officer. He is joined by Robin Harper Cowie, Chief Financial Officer. An audio recording of today’s call and the press release announcement with the quarterly results can be found in the Investor Relations section of the company’s website at biodesix.com.
As today’s call includes forward-looking statements, we encourage you to review the statements contained in today’s press release and the risks and uncertainties described in our SEC filings, which identify certain factors that may cause the company’s actual events, performance and results to differ materially from those contained in the forward-looking statements made on today’s webcast. In addition, we will discuss non-GAAP financial measures on this call. Descriptions of these non-GAAP financial measures and reconciliations of GAAP to non-GAAP financial measures are included in today’s press release.
I would now like to turn the call
Read the full article here
